Probiotics as a Novel Treatment for Non-Alcoholic Fatty Liver Disease; A Systematic Review on the Current Evidences

CONTEXT: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease, with 5-10% of liver having extra fat. Increase in its prevalence in all age groups is linked with obesity and Type II diabetes. The treatment of NAFLD remains controversial. A growing body of evidence suggests a relation...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelishadi, Roya, Farajian, Sanam, Mirlohi, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719124/
https://www.ncbi.nlm.nih.gov/pubmed/23885277
http://dx.doi.org/10.5812/hepatmon.7233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719124/
https://www.ncbi.nlm.nih.gov/pubmed/23885277
http://dx.doi.org/10.5812/hepatmon.7233

Ejemplares similares